Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.

  title={Erythropoietin in traumatic brain injury (EPO-TBI): a double-blind randomised controlled trial.},
  author={Alistair D Nichol and Craig J. French and Lorraine Little and Samir H. Haddad and Jeffrey J Presneill and Yaseen M Arabi and Michael J. Bailey and David Jamie Cooper and Jacques Duranteau and Olivier Huet and Anne Mak and Colin J McArthur and Ville Pettil{\"a} and Markus B Skrifvars and Shirley A. Vallance and Dinesh Kumar Varma and Judy L Wills and Rinaldo Bellomo},
  volume={386 10012},
BACKGROUND Erythropoietin might have neurocytoprotective effects. In this trial, we studied its effect on neurological recovery, mortality, and venous thrombotic events in patients with traumatic brain injury. METHODS Erythropoietin in Traumatic Brain Injury (EPO-TBI) was a double-blind, placebo-controlled trial undertaken in 29 centres (all university-affiliated teaching hospitals) in seven countries (Australia, New Zealand, France, Germany, Finland, Ireland, and Saudi Arabia). Within 24 h… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 109 times over the past 90 days. VIEW TWEETS
39 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 39 extracted citations

Similar Papers

Loading similar papers…